PROTHENA CORP PUBLIC LTD CO
Biotechnology company developing therapies for diseases of protein dysregulation.
PRTA | US
Overview
Corporate Details
- ISIN(s):
- USG728001086 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
- Website:
- https://www.prothena.com/
Description
Prothena Corporation is a late-stage clinical biotechnology company specializing in the science of protein dysregulation. The company leverages its expertise in the biology of misfolded proteins to discover and develop novel therapeutics. Its primary focus is on advancing a diverse pipeline of investigational treatments for neurodegenerative conditions and rare peripheral amyloid diseases. Prothena's scientific approach integrates insights into neurological dysfunction and the mechanisms of protein misfolding to create antibody-based therapies designed to provide clinically meaningful benefits for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PROTHENA CORP PUBLIC LTD CO filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PROTHENA CORP PUBLIC LTD CO
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PROTHENA CORP PUBLIC LTD CO via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
